Data continues to play an ever-increasing role in the healthcare and life sciences industry with the promise to revolutionize care delivery and treatments through individualized approaches derived from highly granular, patient-level data capture and insights. In addition, the movement towards enhanced data analytics, big data use, and AI has raised the bar on data quality and quantity. As a result, patient trust around data capture and use has become more omnipresent than ever and creates challenges and opportunities for various parts of our industry.
The discussion presents leveraging health data, modern infrastructure, and advanced interoperability while enhancing patient trust to drive innovation across companies and the industry as a whole. Panelists represent companies with a combined $1B in funding and includes Canada's largest software company,
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
